Daiichi Sankyo Co Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, everyone. Welcome to the JPMorgan Healthcare Conference. I'm Seiji Wakao, Japan pharma analyst in JPMorgan. And it's my pleasure to introduce Sunao Manabe, CEO of Daiichi Sankyo, and welcome him to the conference. The presentation will be followed directly by Q&A. Audience, you can submit questions any time by using Ask a Question on the data conference book. So please send your questions. For our Q&A session, Wataru Takasaki, Head of R&D Division, will join.
With that, let me turn over to Manabe-san. Please go ahead, Manabe-san.
Thank you, Wakao-san. Good morning, colleagues. My name is Sunao Manabe, and I'm the President and CEO of Daiichi Sankyo. I'm joining this session from our head office in Tokyo. It is really unfortunate that this important conference has to be held in virtual format and that we could not meet in person.
Before I start, I would like
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |